年轻成人非重症新冠感染后股动脉血栓形成一例
本文报告一例24岁男性在非重症COVID-19后发生股动脉血栓形成,表现为右下肢疼痛一个月,影像诊断股总动脉血栓延伸至股浅及股深动脉近端,伴胫后及腘动脉血栓。经抗凝、抗血小板及血栓清除术治疗后好转,病因学评估除非重症COVID-19外均为阴性。作者提示即使感染非重症且患者年轻,也应警惕动脉事件风险。
要点
- 年轻患者非重症COVID-19后仍可发生股动脉血栓形成。
- 病因学评估阴性时需考虑COVID-19相关凝血异常。
- 抗凝联合抗血小板及血栓清除术治疗有效。
核心结论
- 非重症COVID-19年轻患者也可发生股动脉血栓形成,临床应警惕动脉事件风险。
研究设计与样本
- 个案报道,描述一例24岁男性非重症COVID-19后股动脉血栓形成的诊治经过。
主要发现
- 24岁男性右下肢疼痛一个月,诊断股总动脉血栓延伸至股浅及股深动脉近端,伴胫后及腘动脉血栓。
- 经抗凝、抗血小板及血栓清除术治疗后 evolution 良好。
- 病因学评估除非重症COVID-19外均为阴性。
关键数值与推荐
- 原文未报告具体抗凝或抗血小板药物剂量及疗程。
- 原文未报告动脉血栓栓塞预防的明确推荐。
临床怎么用
- 对非重症COVID-19年轻患者出现肢体缺血症状时应考虑动脉血栓栓塞可能。
- 治疗可采用抗凝、抗血小板药物及血栓清除术。
- 重症感染或ICU患者推荐预防静脉血栓栓塞,但动脉血栓栓塞预防无明确推荐。
局限性
- 单一个案报道,证据级别有限。
- 病因学评估未完全排除其他潜在血栓形成因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Few cases of arterial thromboembolisms have been reported after novel coronavirus disease 2019 (COVID-19) in case of severe infection or in elderly patients. We report a case of femoral arterial thrombosis in a young patient after nonsevere infection. CASE DESCRIPTION: A common femoral artery thrombosis extended in the first third of superficial and profunda femoral arteries associated with tibial posterior and popliteal artery thrombosis was diagnosed in a 24-year-old man complaining of right lower limb pain for one month. The evolution was good after anticoagulation and antiaggregant treatments and thrombectomy. Etiologic assessment was negative except for nonsevere COVID-19. DISCUSSION: COVID-19 accesses host cells via angiotensin-converting enzyme 2 protein, abundant in the lungs, which is also expressed by endothelial cells and is associated with important inflammatory syndrome and coagulopathy, leading to vascular lesions. Thrombosis prevalence is not fully established and seems to be higher in case of major inflammation and in the intensive care unit (ICU). Arterial thromboembolisms are described in many vascular territories, each time in elderly patients, or in case of severe infection. We described a femoral arterial thrombosis in a young patient with negative etiological assessment except nonsevere COVID-19. Treatment consists in anticoagulation and antiaggregant drugs and thrombectomy. Preventing venous thromboembolism treatment is recommended in case of severe infection or in the ICU, but there is no clear recommendation for arterial thromboembolism prevention. This case should lead us to be very careful of the arterial event risk even if the infection is nonsevere and the patient is young.
引用
- Veyre F, Poulain-Veyre C, Esparcieux A, et al. Femoral Arterial Thrombosis in a Young Adult after Nonsevere COVID-19. Ann Vasc Surg. 2020. PMID: 32736027. doi:10.1016/j.avsg.2020.07.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。